Physician profile
Divjot Kaur
NPI 1285466532
$805.15
in general payments reported to CMS, 2019-2025
16 companies · $756 in 2025
The $756 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $49.41 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $139.97 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Lilly USA, LLC | $114.06 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $80.25 | 2025 | |
| Sumitomo Pharma America, INC. | $49.10 | 2025 | Gemtesa |
| Astellas Pharma US INC | $47.19 | 2025 | Veozah |
| Abbvie INC. | $47.11 | 2025 | |
| Glaxosmithkline, LLC. | $45.91 | 2025 | Shingrix, Trelegy Ellipta |
| Axsome Therapeutics, INC. | $44.29 | 2025 | Auvelity |
| Insulet Corporation | $40.88 | 2025 | Omnipod |
| Merck Sharp & Dohme LLC | $40.16 | 2025 | Capvaxive, Gardasil 9 |
| Novo Nordisk INC | $37.14 | 2025 | Rybelsus, Ozempic, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $29.82 | 2025 | Caplyta |
| Edwards Lifesciences Corporation | $27.01 | 2024 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $26.41 | 2025 | |
| Phathom Pharmaceuticals, INC. | $22.18 | 2025 | Voquezna |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.67 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divjot Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.